Molecular Docking and Dynamics Simulation study for Anticancer Phytoconstituents inhibiting breast cancer

Author:

Singh Nootan,Yadav Piyush Kumar,Singh Ajay Kumar,Gupta Divya,Gupta Garima

Abstract

The main challenge in the fight against breast cancer (BC) is to create new medications that are more selective for cancer cells and have fewer adverse effects. SPDEF (Sam pointed domain containing ETS transcription factor) is a prostate-derived ETS factor that maintains homeostasis, differentiation of epithelial tissues and heritable alterations in cancer. Previously, SPDEF has been shown to be associated with BC subtypes and is found to be down-regulated in invasive breast cancer cell lines which is supportive of its role in tumor suppression. In the current study, SPDEF protein was used as a potential breast cancer therapeutic target. A total of fifteen phytoconstituents were evaluated as potential drug ligands against SPDEF using various in silico approaches. Genistein, allicin, 2-hydroxychalcone and ajoene were free from any of the predicted toxicological endpoints. As per toxicological endpoints prediction study, the median lethal dosage (LD50) values for these phytoconstituents varied from 159 to 3919 mg/Kg. Our results indicate that out of fifteen, three phytoconstituents silibinin (-7.7 kcal/mol), codonolactone (-6.1 kcal/mol) and genistein (-6.1 kcal/mol), showing the lowest binding energies, had more significant inhibitory effects against SPDEF protein. We selected these three phytoconstituents on the basis of binding scores for molecular dynamic simulations at 200 ns to study their protein-ligand complex stability. Out of the three, silibinin-receptor complex had more stability. The present analysis shows that silibinin could be a potential therapeutic compound against breast cancer as assessed by its binding interaction and stability analyses against SPDEF.

Publisher

World Researchers Associations

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3